Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single‐Center Experience

@article{Kanjwal2011PyridostigmineIT,
  title={Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single‐Center Experience},
  author={Khalil Kanjwal and B. Karabin and M. Sheikh and L. Elmer and Y. Kanjwal and Bilal Saeed and B. Grubb},
  journal={Pacing and Clinical Electrophysiology},
  year={2011},
  volume={34}
}
Background:  The long‐term efficacy of pyridostigmine, a reversible acetyl cholinesterase inhibitor, in the treatment of postural orthostatic tachycardia syndrome (POTS) patients remains unclear. We report our retrospective, single‐center, long‐term experience regarding the efficacy and adverse effect profile of pyridostigmine in the treatment of POTS patients. 
Acute Water Ingestion as a Treatment for Postural Orthostatic Tachycardia Syndrome
TLDR
A novel approach to acute treatment for POTS is discussed, which was able to replicate her symptoms, which were due to tachycardia in a standing position that resolved upon sitting, after being offered eight ounces (236.6 mL) of water and, after consumption of such, the standing tachycardsia was no longer observed. Expand
Overview of the management of postural tachycardia syndrome in pregnant patients
TLDR
The management of POTS in the pregnant and obstetric settings is discussed. Expand
Diagnosis and management of postural orthostatic tachycardia syndrome: A brief review
TLDR
This syndrome appears to describe a group of conditions with differing pathophysiology, which requires treatment tailored to the true underlying disorder, which needs to be fully evaluated to guide treatment. Expand
Postural orthostatic tachycardia syndrome (POTS) occurring during treatment for breast cancer
TLDR
A case of a middle-aged woman presenting with a new onset of POTS likely due to chemotherapy for treatment of breast cancer is reported, to encourage clinicians to consider POTS as a differential diagnosis, while managing patients with symptoms of orthostatic intolerance. Expand
Postural tachycardia syndrome: current perspectives
TLDR
The factors and mechanisms that may contribute to the symptoms and signs of POTS are reviewed and the perspectives on the clinical approach toward the diagnosis and management of this complex syndrome are presented. Expand
Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar.
TLDR
This review details the most current views on the potential causes, comorbid conditions, proposed subtypes, differential diagnoses, evaluations, and treatment of POTS from cardiological and neurological perspectives. Expand
Evaluating and managing postural tachycardia syndrome
Postural tachycardia syndrome (POTS) is a disorder of the autonomic nervous system with many possible causes, characterized by an unexplained increase in heartbeat without change in blood pressureExpand
Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management
A 29 year-old woman had been well until 7 months previously when, after a viral syndrome, she developed palpitations, fatigue, and frequent episodes of light headedness and near syncope. On furtherExpand
Postural orthostatic tachycardia syndrome (POTS): a common but unfamiliar syndrome.
TLDR
An update on the etiology of POTS, which is still poorly understood, and its overlap with other syndromes such as chronic fatigue syndrome, and two cases illustrating the heterogeneity of this syndrome are reported. Expand
Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes.
Vasovagal syncope, postural orthostatic tachycardia syndrome, and inappropriate sinus tachycardia comprise a heterogenous group of common autonomic disorders that are associated with significantExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
TLDR
The result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension was that most patients were very satisfied with the medication and chose to continue it. Expand
Pyridostigmine for treatment of neurogenic orthostatic hypertension
TLDR
A follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension evaluated self-reported efficacy and patients’ satisfaction with the medication. Expand
The Postural Tachycardia Syndrome: A Concise Guide to Diagnosis and Management
TLDR
The aim of this brief report is to outline the clinical picture, subtypes, diagnosis, and management of POTS. Expand
Pyridostigmine in the Treatment of Orthostatic Intolerance
TLDR
Long-term data are insufficient to support recommending the routine use of pyridostigmine bromide for treatment of orthostatic intolerance, and modest but statistically significant improvements in hemodynamic measurements are found. Expand
[Pyridostigmine in the treatment of primary orthostatic hypotension].
TLDR
Pyridostigmine seems to be as useful as fludrocortisone in the POH treatment and has less side effects, and may be an alternative or a complement in the treatment of the illness. Expand
Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
TLDR
Pyridostigmine significantly improves standing BP in patients with OH without worsening supine hypertension, suggesting that the improvement is due to increased total peripheral resistance. Expand
Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome
TLDR
Acute acetylcholinesterase inhibition significantly attenuated tachycardia in POTS and there was also an improvement in symptom burden with this promising therapy. Expand
The Postural Orthostatic Tachycardia Syndrome:
TLDR
This article presents a review of the pathophysiology, diagnosis, and management of this disorder, generally known as the postural orthostatic tachycardia syndrome (POTS), which has seen a tremendous expansion in knowledge over the last two decades. Expand
Tratamiento de la hipotensión ortostática primaria con piridostigmina
TLDR
Pyridostigmine seems to be as useful as fludrocortisone in the POH treatment and has less side effects, and this new strategy may be an alternative or a complement in the treatment of the illness. Expand
Orthostatic Hypotension:
TLDR
Any disturbance in autonomic function that results in sympathetic failure can cause orthostatic (or positional) hypotension which, if sufficiently profound, can produce cerebral hypoperfusion, near syncope, and syncope. Expand
...
1
2
...